|
|
|
|
|
Detail |
hsa-miR-20a |
|
Unspecified |
WITHDRAWN:MicroRNA profile in peripheral blood T cells of patients with primary biliary cirrhosis. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. |
2006 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. |
2007 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
A microRNA cluster as a target of genomic amplification in malignant lymphoma. |
2005 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. |
2007 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. |
2005 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
|
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. |
2008 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Causal |
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. |
2009 |
|
|
|
|
|
|
hsa-miR-20a |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|